Small study dives into how new drug works for ulcerative colitis
NCT ID NCT03100864
First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 26 times
Summary
This study looked at how a new medicine, BI 655130, affects the body in 8 adults with moderate to severe ulcerative colitis. The main goal was to understand the drug's mechanism by measuring changes in gene activity in the gut lining. Researchers also checked for safety and signs of improvement, but this was an early exploratory trial, not a test for a cure.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLITIS, ULCERATIVE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Addenbrooke's Hospital
Cambridge, CB2 0QQ, United Kingdom
-
Asklepios Kliniken Westklinikum Hamburg
Hamburg, 22559, Germany
-
UZ Leuven
Leuven, 3000, Belgium
-
Universitätsklinikum Schleswig-Holstein, Campus Kiel
Kiel, 24105, Germany
Conditions
Explore the condition pages connected to this study.